Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06288997 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TACS Intervention for Methamphetamine Addiction

Study acronym: tACS for MUD
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Enrollment target: 23 to 70v2 Show 9 more changesShow less
    • Primary completion date: May 9, 2023 to Sep 1, 2025
    • Primary endpoints: 1 to 2
    • Trial status: Completed to Active, Not Recruiting
    • Study sites: 1 to 5
    • Study completion date: Nov 9, 2023 to Dec 31, 2025
    • Interventions: sham tACS (Device), transcranial alternating current stimulation (Device) to Active transcranial alternating current stimulation (Device), Sham transcranial alternating current stimulation (Device)
    • Eligibility criteria expanded, about 75 words
    • Secondary endpoints: 8 to 6
    • Study description shortened, about 264 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In 2021, nearly 296 million people worldwide used psychoactive substances, highlighting a significant need for effective interventions for disorders such as Methamphetamine Use Disorder (MUD). Despite existing treatments, including behavioral therapies and medications, the relapse rates remain high, signaling the need for more potent and targeted approaches. This clinical trial investigates high-intensity transcranial alternating current stimulation (Hi-tACS), a non-invasive method that applies 15mA electrical currents with a patented frequency of 77.5Hz to modulate brain activity. Hi-tACS has shown promise in preliminary studies for its ability to reduce drug cravings significantly by influencing brain regions crucial in addiction. The primary aim of this study is to evaluate the effectiveness of Hi-tACS in curbing cravings in individuals with MUD. As secondary objectives, the trial will also explore the potential benefits of Hi-tACS in alleviating other clinical symptoms, enhancing cognitive performance, and positively influencing brain activity. This study seeks to establish Hi-tACS as a more effective treatment option that could lead to substantially lower relapse rates for individuals with MUD.
Trial Details
NCT Number NCT06288997
Lead Sponsor Shanghai Mental Health Center
Conditions
(from sponsor)		 Methamphetamine Use Disorder
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov